Japanese Drug Major Destroys A Worthy Indian Competitor To Big Pharma

It does not look like Daiichi wanted to run the company. They seem anxious to burn the company’s cash pile. My guess is that Ranbaxy will be asked to take on excessive debt and collapse or become just another distributor of drugs developed abroad. The DIIP is right. The huge buyouts of Indian pharma companies are driven by the intense desire of Big Pharma to eliminate competition. Or, else how can shards of glass be found in medicine vials. THIS IS JUST SABOTAGE.

Advertisements

Comments on this blog are moderated by government agents. The Moral Volcano Essential Reading List will explain why.

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s